Blood marker test to track response to cancer treatment
Treatments studied
Part of Cancer clinical trials.
This study looks for new blood (serum) markers that may show whether anti-cancer therapy is working. If you have cancer or possible cancer and can safely take part, your blood may be used to monitor treatment response over time.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older (and for some sample parts, at least 20).
- You have a known cancer diagnosis or you are being evaluated for possible cancer.
- Your ability to do daily activities must be fairly good (Karnofsky score above 70).
- You must complete the usual pre-treatment health checks required for cancer care.
- You must sign the study consent form approved by Stanford’s human subjects committee.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study measures “circulating tumor markers,” meaning substances from cancer that can show up in blood, to better understand how cancer is doing after treatment. You may join if you recently received cancer care at a participating center and meet basic study and follow-up requirements.
This study looks for markers of cancer in your blood. It may help doctors learn more about your tumor and how to treat it.
This trial looks at blood samples to measure substances that may reflect cancer (tumor markers). It may help doctors understand cancer better and improve future monitoring, as long as you can safely and regularly take part.
This study looks at a non-invasive blood test to detect cancer-related “signal patterns” and see how well they match different types of cancer. It may help researchers learn better ways to find or understand cancer using less invasive testing.
This study is looking at a blood marker (a type of chemical change in cells) to see if it can help predict how solid tumor cancers will behave. If you have a solid tumor cancer, this research might help doctors understand your condition better.
This study collects extra blood samples during your routine care to look for markers that might help predict how well cancer treatments work and how long people live. Participating involves no extra procedures beyond what you already need.
Hear when a new Neoplasms trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.